SIRS-LAB
SIRS-Lab is a privately held diagnostic company developing unique and innovative products to identify and monitor life-threatening infections, one of the major causes of death in hospitals across the world. SIRS-Lab's vision is to support clinicians in their bedside decisions by providing them with fast and reliable high-performance point of care systems and thus, to improve therapeutic impact and reduce the mortality rate of patients. Founded in 2000 by S. Russwurm, K. Reinhart, E. Straube and H.-P. Saluz, SIRS-Lab employs today 45 people. The company currently commercializes VYOO, a molecular diagnostic test for the rapid identification of sepsis causing bacteria and fungi. Sepsis is one of the major causes of death in hospitals.
SIRS-LAB
Industry:
Biotechnology Health Diagnostics Therapeutics
Founded:
2000-01-01
Address:
Jena, Thuringen, Germany
Country:
Germany
Website Url:
http://www.sirs-lab.com
Status:
Closed
Contact:
49 3641 31 03 100
Email Addresses:
[email protected]
Total Funding:
10 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving Nginx Baidu Analytics 51.la
Investors List
bm-t beteiligungsmanagement thuringen
bm-t beteiligungsmanagement thuringen investment in Venture Round - SIRS-Lab
Affentranger Associates
Affentranger Associates investment in Venture Round - SIRS-Lab
